1. Home
  2. EYEN vs EFSH Comparison

EYEN vs EFSH Comparison

Compare EYEN & EFSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EYEN
  • EFSH
  • Stock Information
  • Founded
  • EYEN 2014
  • EFSH 1948
  • Country
  • EYEN United States
  • EFSH United States
  • Employees
  • EYEN N/A
  • EFSH N/A
  • Industry
  • EYEN Biotechnology: Pharmaceutical Preparations
  • EFSH Professional Services
  • Sector
  • EYEN Health Care
  • EFSH Consumer Discretionary
  • Exchange
  • EYEN Nasdaq
  • EFSH Nasdaq
  • Market Cap
  • EYEN 4.0M
  • EFSH 4.2M
  • IPO Year
  • EYEN 2018
  • EFSH N/A
  • Fundamental
  • Price
  • EYEN $1.68
  • EFSH $0.15
  • Analyst Decision
  • EYEN Hold
  • EFSH
  • Analyst Count
  • EYEN 4
  • EFSH 0
  • Target Price
  • EYEN $2.00
  • EFSH N/A
  • AVG Volume (30 Days)
  • EYEN 267.4K
  • EFSH 2.7M
  • Earning Date
  • EYEN 03-17-2025
  • EFSH 04-16-2025
  • Dividend Yield
  • EYEN N/A
  • EFSH N/A
  • EPS Growth
  • EYEN N/A
  • EFSH N/A
  • EPS
  • EYEN N/A
  • EFSH N/A
  • Revenue
  • EYEN $31,832.00
  • EFSH $69,415,140.00
  • Revenue This Year
  • EYEN $23,413.60
  • EFSH N/A
  • Revenue Next Year
  • EYEN $400.98
  • EFSH N/A
  • P/E Ratio
  • EYEN N/A
  • EFSH N/A
  • Revenue Growth
  • EYEN 2557.10
  • EFSH 228.22
  • 52 Week Low
  • EYEN $1.67
  • EFSH $0.15
  • 52 Week High
  • EYEN $205.60
  • EFSH $717.62
  • Technical
  • Relative Strength Index (RSI)
  • EYEN 27.62
  • EFSH 38.07
  • Support Level
  • EYEN $1.67
  • EFSH $0.15
  • Resistance Level
  • EYEN $1.94
  • EFSH $0.17
  • Average True Range (ATR)
  • EYEN 0.26
  • EFSH 0.02
  • MACD
  • EYEN 0.22
  • EFSH 0.04
  • Stochastic Oscillator
  • EYEN 0.80
  • EFSH 0.00

About EYEN Eyenovia Inc.

Eyenovia Inc is a clinical stage ophthalmic company developing a pipeline of therapeutics based on its propriety array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Opejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies which target new indications or new combinations.

About EFSH 1847 Holdings LLC

1847 Holdings LLC is a diversified holding company. It operates in Four segments: Retail and appliances, Retail and Eyewear, Construction, and Automotive Supplies. The company generates maximum revenue from the Construction segment. The firm, through its subsidiaries, provides a wide range of land application services and sells equipment and parts, primarily to the agricultural, construction, and lawn and garden industries.

Share on Social Networks: